메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색
질문

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색
질문

초록· 키워드

오류제보하기
This study was carried out to assess the potential of intranasal administration of ondansetron (a 5-HT₃ receptor antagonist, which antagonize the acute emetic response) in preventing cisplatin-induced emesis in the ferret. After intranasal administration of ondansetron at doses of 0.3 and 0.6 ㎎/㎏, the peak plasma concentrations (Cmax) were 38 and 66.7 ng/mL, and attained at 13 and 23 min (Tmax) respectively. The intravenous (0.3 ㎎/㎏) and intranasal (0.6 ㎎/㎏) administrations of ondansetron significantly delayed the latency time to the first retching and vomiting. In acute phase of emesis during 24 hr, the number of vomits and retches were significantly reduced both in intravenous and intranasal administration groups. In delayed emesis (24-72 hr), intranasal administration of ondansetron at a higher dose of 0.6 ㎎/㎏ or intravenous injection of 0.3 ㎎/㎏ significantly reduced retching but not vomiting. Intranasal ondansetron, administered as 0.6 ㎎/㎏ dose, provided potency in antiemetic control comparable to intravenous ondansetron (0.3 ㎎/㎏) in cisplatin-induced acute emesis, without well known side effects when injected via intravenously. These results suggest that intranasal administration of ondansetron can be an effective substitute for intravenous administration for the prevention of cisplatin-induced acute emesis.

목차

Materials and Methods
Results
Discussion
Acknowledgments
References

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0

UCI(KEPA) : I410-ECN-0101-2009-510-018879452